KIT is a tyrosine kinase receptor‐encoding gene with its mutations occurring in about 75%–80% gastrointestinal stromal tumors (GIST), 9.5% in melanoma, and 3% in lung cancer. This evidence concerns the gene NTRK1 and melanoma.